Medicenna Therapeutics Corp. - Special Call Transcript
Good afternoon, and welcome to the Medicenna KOL webinar on MDNA55 for the treatment of recurrent glioblastoma multiforme. (Operator Instructions) As a reminder, this webinar is being recorded, and a replay will be made available on the Medicenna website following the event. .
I would now like to turn the call over to your host, Dr. Fahar Merchant, President and Chief Executive Officer of Medicenna. Please go ahead, Doctor.
Thank you, operator. Good morning, everyone, and welcome to today's key opinion leader event. Before I begin, I would like to remind everyone that during the presentations and the Q&A session to follow, forward-looking statements may be made as disclosed on this slide.
Next slide, please. I would also like to thank our key opinion leaders, Dr. David Reardon, Dr. John Sampson; Dr. Ruthie Davi, and Dr. Amy McKee, for graciously taking the time to join us on the webcast today.
Next slide, please. So today's event will focus on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |